Exogenous administration of purified BMSCs is protective in mouse models of organ system injury 1,2 , including sepsis-induced ALI 3,4 , suggesting that BMSCs might be therapeutically effective in this context 5 . However, their protective mechanisms are not entirely clear. BMSCs might improve survival in mice exposed to airway endotoxin instillation by engrafting in the alveolar epithelium and transdifferentiating to form new epithelium 6, 7 , although not all studies have agreed with this hypothesis 8, 9 , or by paracrine secretions of critical repair factors, including keratinocyte growth factor (KGF) 10 , interleukin-10 (IL-10) 11,12 , angiopoietin-1 (refs. 13,14), interleukin-1 receptor antagonist 15 and prostaglandin E2 (PGE2) 16 .
Exogenous administration of purified BMSCs is protective in mouse models of organ system injury 1,2 , including sepsis-induced ALI 3, 4 , suggesting that BMSCs might be therapeutically effective in this context 5 . However, their protective mechanisms are not entirely clear. BMSCs might improve survival in mice exposed to airway endotoxin instillation by engrafting in the alveolar epithelium and transdifferentiating to form new epithelium 6, 7 , although not all studies have agreed with this hypothesis 8, 9 , or by paracrine secretions of critical repair factors, including keratinocyte growth factor (KGF) 10 , interleukin-10 (IL-10) 11, 12 , angiopoietin-1 (refs. 13, 14) , interleukin-1 receptor antagonist 15 and prostaglandin E2 (PGE2) 16 .
As sepsis-induced ALI impairs lung mitochondrial bioenergetics [17] [18] [19] , we considered the alternative possibility that the protective effect of BMSCs involves mitochondrial transfer to host cells. In culture, BMSCs are capable of transferring their mitochondria to endothelial cells, A549 cells and cardiomyocytes [20] [21] [22] . However, in intact lungs in vivo, it is not known whether airway-instilled BMSCs transfer mitochondria to lung cells and whether such a transfer is potentially therapeutic. Here we address these issues using live-lung microscopy 23, 24 .
RESULTS mBMSCs attach to alveoli by forming Cx43-based GJCs
To establish the sepsis-induced ALI model, we airway instilled Escherichia coli LPS in anesthetized mice. As a control, we similarly instilled mice with PBS. We studied the lungs at 4 h and 24 h after these instillations. For the 4-h studies, we isolated and blood perfused the lungs 4 h after the LPS or PBS instillations and then immediately instilled mBMSCs intratracheally and imaged the lungs for a further 4 h 23, 24 . For the 24-h studies, we gave mBMSCs by intranasal instillation in anesthetized mice 4 h after the LPS or PBS instillations and then isolated and blood perfused the lungs after 24 h for the imaging studies.
In the 4-h studies, we delineated the alveolar epithelia by loading the alveoli with a water-soluble fluorescent dye 23, 24 before instilling the mBMSCs. We expressed the mitochondria-targeted fluorescent protein DsRed in the mBMSCs and confirmed that its expression was localized to the mitochondria (Supplementary Fig. 1a ). Minutes after instilling the mBMSCs, we detected DsRed-expressing cells adjacent to the alveolar epithelium (Fig. 1a) , confirming that the mBMSCs reached the alveoli.
In the PBS-instilled lungs (called hereafter PBS lungs), the instilled mBMSCs migrated from deep to superficial regions of the alveoli. Thus, when we viewed alveoli from these lungs in 2-µm optical sections at a fixed focal plane, we detected mBMSCs that emerged from deeper planes and then progressively occupied epithelial sites at more superficial planes at which no mBMSCs were previously present (Fig. 1a) . Accordingly, DsRed fluorescence increased in a time-dependent manner in these lungs at the superficial sites of mBMSC emergence (Fig. 1b) . In the 24-h studies, the PBS lungs no longer contained mBMSCs in the imaged alveoli (Fig. 1c) or in the lung as a whole (Fig. 1d) , although mBMSCs were present in the adjoining subpleural interstitia (Fig. 1c) and in the thoracic lymph nodes (Fig. 1e) .
Compared to the PBS lungs, in the LPS-instilled lungs (called hereafter LPS lungs), the mBMSCs migrated less (Fig. 1b) , the subpleural interstitia contained fewer mBMSCs and the alveoli retained the mBMSCs to a greater extent (Fig. 1c) . In addition, we detected greater numbers of retained mBMSCs in these lungs as a whole using flow cytometry ( Fig. 1d and Supplementary Fig. 1b) . When we airway instilled these lungs with mBMSCs containing a water-soluble dye that had a different fluorescence than that of the epithelial dye, several alveolusattached mBMSCs spontaneously exchanged cytosolic fluorescence with the alveolar epithelium within 30 min of instillation (Fig. 1f) .
As the dyes were membrane impermeable, this intercellular dye exchange suggested the presence of GJCs. To test this possibility, we quantified the fluorescence recovery after photobleaching (FRAP) 20 , which assays GJC-dependent communication. During photobleaching, we imaged multiple optical sections in each cell's depth axis to confirm that the mBMSC fluorescence was lost throughout the cell, thereby ruling out the possibility that the fluorescence recovery was caused by intracellular dye diffusion. FRAP was present in alveolus-attached mBMSCs (Fig. 1f) , confirming the presence of GJCs between the attached cells. Direct intra-alveolar microinfusions of the non-specific GJC blocker α-glycyrrhetinic acid or the specific Cx43-inhibiting peptide GAP26 (refs. 23,25) blocked the FRAP (Fig. 1g) , implicating Cx43 in GJC formation.
Under culture conditions, mBMSCs that express Cx43 with a T-to-A mutation at Thr154 (mutCx43) do not form functional GJCs 20, 26 . Here, mBMSCs expressing mutCx43 had markedly lower concentrations of endogenous Cx43 compared to wild-type mBMSCs (Supplementary Fig. 1c ). These findings indicate that expression of mutant Cx43 in the mBMSCs negatively regulated endogenous Cx43 expression. When we instilled mutCx43-expressing mBMSCs in LPS lungs, they migrated out of the lungs at rates similar to those of wildtype mBMSCs in the PBS lungs (Fig. 1d,e) . The mBMSCs expressing mutCx43 did not develop spontaneous dye exchange (data not shown) or FRAP (Fig. 1g) , indicating that wild-type Cx43 expression in the mBMSCs was essential for GJC formation and alveolar attachment. Spontaneous dye transfer and FRAP were also absent under control conditions (instillation of PBS instead of LPS or of 3T3 cells instead of mBMSCs) (data not shown).
Within 4 h after airway instillation of LPS alone (that is, in the absence of instilled mBMSCs or other cells), Cx43 fluorescence of the alveolar epithelia increased markedly (Fig. 2a) , indicating that LPS alone induced a Cx43-rich alveolar membrane before the alveolar arrival of mBMSCs. Line-scan fluorescence analyses in LPS lungs revealed that the distribution of Cx43 in the alveolar epithelia was spatially uneven and that the mBMSC attachment occurred at sites of high Cx43 expression (Fig. 2b) . To determine Cx43 expression in the lungs as a whole, we instilled LPS or PBS, but no mBMSCs, in mice. Then, in primary isolates of mouse alveolar type II (AT2) cells 27 and in membrane fractions that we recovered from the lungs 4 h afterwards, mRNA analyses and immunoblots indicated that Cx43 expression was higher in LPS lungs than in PBS lungs (Fig. 2c) . However, 24 h after instillation, the expression of Cx43 was similar in the two groups (Fig. 2c) . In isolated AT2 cells and in an uncharacterized mixture of lung cells, mRNA analyses for known alveolar connexins 23 revealed that the mBMSCs expressed only Cx43 and that Cx43 was the only connexin that was common to both the lung cells and the mBMSCs (Fig. 2d) . These findings implicate Cx43 as the essential connexin in the GJC formation that we detected between the mBMSCs and the alveolar epithelium. As 3T3 cells also express Cx43 (ref. 28 ) but did not form GJCs in the LPS lungs (as described above), we investigated the effects of cell suspension, a condition to which we exposed the mBMSCs and the 3T3 cells for ~2 h before airway instillation. Cx43 expressions were similar in plated mBMSCs and 3T3 cells. However, after we suspended the 3T3 cells for 2 h in medium, the expression of Cx43 was 44% lower in the 3T3 cells than in the mBMSCs (Supplementary Fig. 2a) . The loss of Cx43 in suspended 3T3 cells might account for the inability of these cells to form GJCs with the alveolar epithelium in vivo. 
Alveolus-attached mBMSCs form nanotubes and microvesicles
Within 4 h after instillation of DsRed-expressing mBMSCs, LPStreated lungs, but not PBS-treated lungs, showed that approximately half of the alveolus-attached mBMSCs had generated microvesicles and nanotubes ( Fig. 3a,b) . The released microvesicles were DsRed positive, and they moved away from the cell body at a rate (1.8 ± 0.5 µm min −1 (mean ± s.e.m.)) similar to that of the flow of the alveolar wall liquid 24 ( Fig. 3a) , suggesting that the microvesicles contained mitochondria and were convectively transported. When plated in culture, wild-type mBMSCs displayed similar behavior in that they spontaneously formed mitochondria-transporting nanotubes ( Supplementary  Fig. 2b ). These plated wild-type mBMSCs intercommunicated induced increases in the fluorescence of a dye that reports the cytosolic Ca 2+ concentration, an effect that was not present in mBMSCs expressing mutCx43 ( Supplementary Fig. 2c ), suggesting that the Ca 2+ communication was GJC dependent. Although mutCx43-expressing mBMSCs also formed nanotubes in culture (data not shown), they did not support Ca 2+ communication (Supplementary Fig. 2c ). Moreover, they did not form nanotubes or microvesicles when they were airway instilled in LPS lungs (Fig. 3b) , presumably because they did not attach to alveoli (Fig. 1d,g ). Nanotubes and microvesicles also did not form in wild-type mBMSCs that we instilled in PBS lungs or in 3T3 cells that we instilled in LPS lungs (data not shown). Microvesicle budding was not present in a subset of wild-type mBMSCs that did not form GJCs in LPS lungs, indicating that mBMSC attachment to the alveolar epithelium was essential for this budding to occur. Flow cytometry determinations in the supernatants of LPS lungs indicated that mBMSC microvesicle formation was extensive in these lungs as a whole ( Fig. 3c) , increasing in the 4 h after mBMSC instillation but decreasing at 20 h after instillation ( Fig. 3c and Supplementary Fig. 2d ).
To gain mechanistic insights into nanotube formation 22,29 , we airway instilled wild-type mBMSCs containing a cytosolic Ca 2+ indicator in LPS and PBS lungs. In the LPS lungs, but not the PBS lungs, alveolar attachment caused time-dependent increases in Ca 2+ concentration in the mBMSCs (Fig. 3d-f) . As alveolar treatment with GAP26 blocked this effect (Fig. 3f) , it seems that the Ca 2+ increase was GJC dependent. When we instilled LPS lungs with mBMSCs that we previously loaded with a Ca 2+ chelator, the mBMSCs successfully attached to the alveolar wall but did not increase their Ca 2+ concentrations or form nanotubes and microvesicles (Supplementary Fig. 2d ), suggesting that these structural responses resulted from gap junctional Ca 2+ communication.
mBMSCs transfer mitochondria to the alveolar epithelium In the LPS lungs from the 4-h studies, mitochondrial transfer was evident by the loss of DsRed fluorescence in alveolus-attached mBMSCs and by the gain of this fluorescence by the adjoining epithelium. We did not see mitochondrial transfer in the PBS lungs in the 4-h studies. When we imaged the alveolar epithelia of LPS lungs at different optical sections, the epithelial internalization of the mBMSC mitochondria was evident in the merging of the colors from DsRed and calcein, which resulted in intermediate pseudocolors in the epithelial cytosol (Fig. 3g) . Trypan Blue, a cell-impermeable fluorescence quencher that decreases extracellular fluorescence 30 , did not decrease the DsRed fluorescence (data not shown), confirming that the DsRed fluorescence was internalized. After the mitochondrial transfer, mBMSC cell bodies lacking DsRed-labeled mitochondria remained attached to the apical alveolar epithelia (Fig. 3g) but did not intercalate in the alveolar wall.
The possibility that mBMSC microvesicles were engulfed by the epithelium was indicated by the fact that the dynamin inhibitor 31 dynasore blocked the mitochondrial transfer (Fig. 3h) , implicating endocytosis in the engulfment mechanism. In support of this possibility, DsRed-positive microvesicles, which we recovered from LPS lungs in which we previously instilled wild-type mBMSCs, stained positively for Cx43 (Supplementary Fig. 2e) . Further, instillation of mutCx43-expressing mBMSCs instead of wild-type mBMSCs led to markedly lower recovery of microvesicles from LPS lungs (Fig. 3b) .
Internalization of DsRed-expressing mBMSC mitochondria was most clearly evident in AT2 cells 24 h after the instillation of LPS and mitochondrial-DsRed-expressing mBMSCs. To determine the internalization in AT2 cells, we loaded alveoli with fluorescent surfactant protein B (SPB) that localizes to lamellar bodies that are present only in AT2 cells (Fig. 4a) . Alveolar type 1 (AT1) cells, comprising the alveolar segment that lacked SPB fluorescence, did not show evidence for DsRed internalization. We imaged single AT2 cells by confocal microscopy in a series of 1-µm optical sections along the depth axis from the plane of the alveolar lumen toward the pleural plane. During this serial imaging, the images transitioned from dark signals at the air-filled plane to fluorescent signals at the cytosolic planes of the AT2 cell. Also evident were mBMSC mitochondria as DsRed-containing particles that were interspersed with perinuclear lamellar body clusters (Fig. 4b) , affirming the intracellular localization of the acquired mitochondria in AT2 cells.
To further validate the mitochondrial transfer, we prepared LPS or PBS lungs as described above, except that we instilled hBMSCs instead of mBMSCs. Twenty-four hours after these instillations, we isolated the AT2 cells and a mixed population of lung cells ( Supplementary  Fig. 3a-f ) in which we PCR amplified DNA sequences coding for human cytochrome oxidases 1 and 2 (CO1 and CO2) (Fig. 4c and  Supplementary Fig. 3g ), which are transcribed by mitochondrial DNA. The presence of these human DNA sequences in mouse AT2 cells derived from LPS lungs but not PBS lungs further affirmed that after LPS-induced lung injury, AT2 cells acquired mitochondria from the instilled hBMSCs. In support of this, we carried out flow cytometry studies on primary isolates of lung cells from LPS and PBS lungs. In LPS lungs, DsRed-and SPB-positive cells localized in the same cell cluster, which is consistent with the interpretation that the mBMSC mitochondria were located in the AT2 cells (Fig. 4d and  Supplementary Fig. 3h,i) . No mitochondrial transfer was evident in PBS lungs after instillation of wild-type mBMSCs or in LPS lungs after instillation of mutCx43-expressing mBMSCs (Fig. 4d) .
mBMSC mitochondria increase alveolar ATP We confirmed that the concentration of ATP was lower in the LPS lungs than in the PBS lungs 32, 33 . We showed further that after we instilled wild-type mBMSCs, the concentrations of ATP were similar in the two groups (Fig. 5a) . Major ATP production in the lung occurs through mitochondrial electron transport, which is inhibited by siRNA knockdown of the Rieske iron-sulfur protein (RISP) of complex III 30, 34 . In cultured mBMSCs expressing anti-RISP siRNA (siRISP), but not scrambled siRNA (scRISP), ATP concentrations were less than in wild-type mBMSCs ( Supplementary Fig. 4a,b) . These findings affirm the role of RISP in ATP production in mBMSCs.
Expression of siRISP did not adversely affect the mBMSCs in culture in that the BMSCs expressing siRISP showed no evidence of apoptosis (Supplementary Fig. 4c ) and their mitochondrial protein content was not different from that of wild-type mBMSCs (data not shown). The siRISP-expressing mBMSCs were functionally competent, forming alveolar attachments (data not shown) and transferring mitochondria to AT2 cells (Supplementary Fig. 3i) . However, neither siRISP-expressing nor mutCx43-expressing mBMSCs could rescue ATP production in LPS lungs (Fig. 5a) .
The availability of the fluorescent ATP probe GlnKII-GFP (Perceval) 35 enabled direct determinations of single-cell ATP concentrations in live alveoli. We confirmed expression of the probe in LPS and PBS lungs by immunoblotting for GFP in the lung tissue (Supplementary Fig. 5a ). Both immunofluorescence and GFP fluorescence of the probe were widely expressed in the alveolar epithelia in all regions of the lung's surface (Fig. 5b) . We confirmed that the expressed ATP fluorescence was appropriately responsive to cell ATP concentrations, which we altered through glucose depletion and replenishment in the lung perfusate (Supplementary Fig. 5b ) 35 .
In the 24-h experiments, alveolar ATP fluorescence was lower in LPS lungs than in PBS lungs (Fig. 5b) . However, in both groups of lungs, the fluorescence was similar after we instilled wild-type, but not mutCx43-expressing, mBMSCs (Fig. 5b,c) . In the LPS lungs, mitochondrial transfer to a localized alveolar segment increased the ATP fluorescence not only throughout the same alveolus but also in 8-10 of the adjacent alveoli (Fig. 5d) . Within 5-8 h of instilling the mBMSCs in both groups, time-lapse imaging indicated that the increase of ATP fluorescence spread progressively from the site of mitochondrial transfer to other sites in the alveolar wall (Fig. 5e) . In the absence of mBMSC instillation, time-lapse ATP fluorescence tended to decrease, although this change was not statistically significant (Fig. 5f) . mBMSC mitochondria protect against ALI To assay an ATP-dependent alveolar functional response, we quantified surfactant secretion of intact alveoli from AT2 cells as the rate of lamellar body exocytosis that was responsive to a brief lung expansion 36 . LPS lungs, but not PBS lungs, lacked this secretory response. However, we could induce the secretion in LPS lungs by instilling wild-type mBMSCs (Fig. 6a,b) but not mBMSCs expressing siRISP or mutCx43 (Fig. 6a,b) .
Globally, LPS induced the responses expected to result from ALI, namely increased leukocytosis in the bronchoalveolar lavage (BAL) (Fig. 6c) , increased albumin leakage in the BAL ( Supplementary  Fig. 6 ) and decreased mouse survival time (Fig. 6d) . In confirmation of previous reports 11, 16 , wild-type mBMSCs markedly abrogated these responses. Our new findings are that the instillation of mBMSCs expressing siRISP, siRNA against Cx43 or mutCx43 did not ameliorate the effects of LPS on BAL leukocytosis or mouse survival (Fig. 6c,d ).
DISCUSSION
Our findings indicate that alveolar attachment and, hence, lung retention of the migration-prone BMSCs, is crucial for the ensuing protective effects against ALI. After alveolar attachment in LPS lungs, BMSCs transferred their mitochondria to the alveolar epithelium, an event that occurred progressively for 24 h, accounting for their protective effect. BMSCs carrying defective mitochondria did not confer such protection. Cx43 was the crucial factor underlying the alveolar attachment of wild-type BMSCs that generated Cx43-expressing nanotubes and microvesicles in a Ca 2+ -dependent manner in LPS lungs. Epithelial engulfment of the released microvesicles might have contributed to the mitochondrial transfer. Microvesicles formed extensively in the LPS lungs, and their parenchymal dispersal might have been convective 24, 37 . Together, these findings provide the first in vivo evidence, to our knowledge, that BMSCs establish epithelial interactions in LPS lungs, form microstructures and transfer their mitochondria to host cells.
This mitochondrial transfer increased alveolar ATP concentrations in LPS lungs in a Cx43-dependent manner. Single-cell ATP determinations, the first in an intact organ, to our knowledge, indicated that the increase in ATP concentration occurred at the transfer site as well as in the adjoining alveoli, affirming that the transferred mitochondria were live and capable of ATP generation in the recipient epithelium. Inflation-induced alveolar surfactant secretion, a major ATP-dependent process that regulates alveolar stability 38, 39 , provides a functional metric of alveolar bioenergetics. That we could induce this secretion in LPS lungs only after instillation of wild-type BMSCs, but not of BMSCs carrying dysfunctional mitochondria, underlines the key role of bioenergetics restoration in cell repair therapy.
We confirmed that the instillation of mBMSCs increased mouse survival in LPS-induced ALI 11 , and we showed further that this survival advantage was lost if the mBMSCs contained dysfunctional mitochondria or GJC-incompetent Cx43 or if they were depleted of Cx43. These findings further support Cx43-dependent mechanisms and the transfer of viable mitochondria in the protective response of mBMSCs. Although long-term consequences of mitochondrial transfer are currently not understood, the transfer was evidently sufficiently rapid to be protective in the acute phase of lung injury.
An unresolved issue is the relative role of paracrine secretion 11, 12, 16 compared to that of mitochondrial transfer in the BMSC protective effect. Although mitochondrial loss in alveolus-attached BMSCs could decrease ATP concentrations in these cells, thereby decreasing their secretory capacity, protective paracrine secretions could continue from nonattached, mitochondria-competent BMSCs. The combined effects of these different sets of BMSCs require further clarification. Also unclear is how an increase of alveolar ATP concentrations repairs the alveolar epithelial and endothelial barriers that are pathologically defective in ALI. Although these issues require attention, we propose that exogenous BMSCs provide a 'Trojan horse' therapeutic strategy for supplying fresh mitochondria to injured cells, thereby enhancing cellular bioenergetics and improving organ function in ALI and other inflammatory diseases.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
